Thursday, 29 December 2022

Pfizer Hemophilia Gene Therapy Hits Goal in Final-Stage Study



from Bloomberg https://ift.tt/faQpx9X

No comments:

Post a Comment

At an ex-OpenAI researcher's influential lab, $500,000 salaries aren't enough to fix a talent 'bottleneck'

METR's CEO, Beth Barnes, and president, Chris Painter. METR METR, a Berkeley lab started by an ex-OpenAI researcher, has grown into a pr...